Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of routine fetal ultrasonographic screening on the prevalence of Down syndrome in non aged mothers.

Annales de genetique - 1 Jan 1998

Stoll C, Alembik Y, Dott B

Abstract excerpt

In many countries the introduction of screening programs based on maternal serum has reduced the number of Down syndrome. In France routine maternal serum screening was not available whereas ultrasound scanning during pregnancy is routine practice in private offices and in hospitals using high-resolution real-time scanners and there are no legal upper limits on gestational age at termination of pregnancy for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Abnormalities, Multiple
Share to Genetic Testing
Share to Infant, Newborn

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Karyotyping

Share to Phenotype

Share to Pregnancy

Share to Prevalence

Share to Sensitivity and Specificity

Source

Identifiers

PMID: 9599648

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of routine fetal ultrasonographic screening on the prevalence of Down syndrome in non aged mothers.PMID 9599648Read ↗

Twenty-year trends in the prevalence of Down syndrome and other trisomies in Europe: impact of maternal age and prenatal screeningSemantic proximity Read ↗

Second trimester prenatal screening for Down's syndrome using alpha‐fetoprotein and free beta hCG: a seven year reviewSemantic proximity Read ↗

Impact of prenatal screening and diagnostic testing on trends in Down syndrome births and terminations in Western Australia 1980 to 2013Semantic proximity Read ↗

Prenatal Screening for Down's Syndrome with Use of Maternal Serum MarkersSemantic proximity Read ↗

Screening of Maternal Serum for Fetal Down's Syndrome in the First TrimesterSemantic proximity Read ↗

Second trimester serum tests for Down's Syndrome screeningSemantic proximity Read ↗

Prenatal Evaluation of MicroRNA Expressions in Pregnancies with Down SyndromeSemantic proximity Read ↗

First and Second Trimester Antenatal Screening for Down's Syndrome: The Results of the Serum, Urine and Ultrasound Screening Study (SURUSS)Semantic proximity Read ↗

New estimates of down syndrome risks at chorionic villus sampling, amniocentesis, and livebirth in women of advanced maternal age from a uniquely defined populationSemantic proximity Read ↗

Accuracy of clinical diagnosis in Down's syndromeSemantic proximity Read ↗

Maternal serum Down syndrome screening: Free β-protein is a more effective marker than human chorionic gonadotropinSemantic proximity Read ↗

The impact of crown–rump length measurement error on combined Down syndrome screening: a simulation studySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.